Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
Hum Gene Ther
; 18(8): 701-11, 2007 Aug.
Article
em En
| MEDLINE
| ID: mdl-17678438
ABSTRACT
We previously demonstrated that adoptively transferred, interleukin (IL)-2-activated natural killer (A-NK) cells are effective in reducing B16 lung tumors in tumor-bearing animals. This effect depends on high and often toxic doses of IL-2 to support the survival and antitumor functions of the transferred A-NK cells. We hypothesized that A-NK cells transduced to express pro-NK cell cytokines would become less dependent on high and potentially toxic amounts of IL-2. Here, we demonstrate that A-NK cells adenovirally transduced to express mIL-12 survive well and function efficiently in mice bearing B16 lung tumors when supported with low, nontoxic doses of IL-2. The intratumoral survival of nontransduced "bystander'' A-NK cells also increased when they were coinjected with IL-12 gene-transduced A-NK cells. The enhanced survival of exogenously delivered, IL-12 gene-transduced A-NK cells resulted in greater antitumor responsiveness. This led to a 7- to 10-day increase in median survival time compared with tumor-bearing mice receiving mock-transduced A-NK cells. These data show that the presence of IL-12 around tumor-infiltrating A-NK cells enhances their antitumor activity while reducing their requirement for systemically administered IL-2.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Células Matadoras Naturais
/
Terapia Genética
/
Adenoviridae
/
Subpopulações de Linfócitos
/
Interleucina-12
/
Neoplasias
Limite:
Animals
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article